Brands and Products
Chemours uses the power of chemistry to create better, reliable solutions.
Medical
Advanced performance materials are reshaping what’s possible in medical device design.
Corporate Responsibility
Creating a better world through responsible chemistry.
Our 2030 Goals
Our progress toward achieving Chemours’ Corporate Responsibility Commitment goals.
The Next Normal
Chemistry will help society navigate a new and better time.
Showing 211-220 of 266 results
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced it will release second quarter financial results after market close on August 8, 2016 .
Agreement Marks Completion of Chemical Solutions Portfolio Review-Part of Chemours Transformation Plan The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, has signed a definitive agreement to sell the assets which comprise its Sulfur Products business, part of its Chemical Solu...
The Chemours Company ( Chemours ) (NYSE: CC) strongly refutes the report by Citron Research issued today.
Bryan Snell, Business President, Will Discuss Chemours Business and How Expansion Supports Chemours Transformation Plan at Goldman Sachs Basic Materials Conference Today The Chemours Company (" Chemours ") (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced that it has begun the commercial startup of ...
The Chemours Company (" Chemours ") (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that it has extended its previously announced offer (the "Exchange Offer") to exchange any and all of its $1,350 million aggregate principal amount of 6.625% Senior Notes due 2023 (the "2023 Notes"), $750 million a...
This Investment in a Cornerstone Growth Opportunity is Part of Company's Transformation Plan The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, takes another step in its five-point transformation plan by investing in large-scale manufacturing to expand supply of its Opte...
First Quarter 2016 Highlights Net sales of $1.3 billion Adjusted EBITDA of $128 million Adjusted Net Income of $11 million , or $0.06 per diluted share Net Income of $51 million , or $0.28 per diluted share, including $89 million gain on sale of Beaumont aniline facility, interest expense of $57 million and restructuring costs of $17 million Other Highlights Continued to build liquidity through wo...
The Chemours Company ( Chemours ) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that Thierry Vanlancker , president of its fluoroproducts business, is retiring. Paul Kirsch , senior vice president, supply chain and operations at Henkel AG & Company , will take over Vanlancker's r...